Halozyme Therapeutics
HALO
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -3.03%536.25M | -8.92%445.73M | -36.95%430.76M | -34.56%361.04M | -34.56%361.04M | 46.83%553.03M | 143.75%489.37M | 1,477.20%683.18M | 868.05%551.68M | 868.05%551.68M |
-Cash and cash equivalents | -3.03%536.25M | -8.92%445.73M | -36.95%430.76M | -34.56%361.04M | -34.56%361.04M | 46.83%553.03M | 143.75%489.37M | 1,477.20%683.18M | 868.05%551.68M | 868.05%551.68M |
Receivables | 0.01%615.57M | 2.00%616.04M | -5.06%615.56M | -5.67%633.74M | -5.67%633.74M | 2.76%615.51M | -3.16%603.94M | -1.09%648.34M | 2.13%671.81M | 2.13%671.81M |
-Accounts receivable | 0.24%608.79M | 1.99%605.23M | -5.16%604.54M | -5.15%624.45M | -5.15%624.45M | 3.02%607.32M | -3.64%593.41M | -0.70%637.44M | 2.50%658.32M | 2.50%658.32M |
-Other receivables | -17.29%6.78M | 2.64%10.81M | 1.07%11.02M | -31.08%9.3M | -31.08%9.3M | -13.24%8.2M | 35.02%10.53M | -19.26%10.91M | -12.93%13.49M | -12.93%13.49M |
Other current assets | -13.46%63.91M | -26.37%37.25M | -27.49%49.67M | -30.76%55.54M | -30.76%55.54M | -22.63%73.85M | -17.05%50.58M | -2.11%68.49M | 10.15%80.22M | 10.15%80.22M |
Total current assets | -2.15%1.22B | -3.92%1.1B | -21.72%1.1B | -19.44%1.05B | -19.44%1.05B | 16.00%1.24B | 29.20%1.14B | 82.12%1.4B | 65.53%1.3B | 65.53%1.3B |
Non current assets | ||||||||||
Net PPE | -1.03%509.27M | -0.33%513.68M | -1.42%513.6M | -1.84%525.66M | -1.84%525.66M | -4.33%514.58M | -5.19%515.39M | -3.85%520.99M | -3.42%535.5M | -3.42%535.5M |
-Gross PPE | 1.70%1.15B | -0.22%1.15B | 0.81%1.15B | 0.53%1.15B | 0.53%1.15B | -0.55%1.13B | -0.43%1.15B | 0.11%1.14B | 0.40%1.15B | 0.40%1.15B |
-Accumulated depreciation | -3.99%-640.77M | 0.13%-634.02M | -2.68%-640.15M | -2.60%-626.03M | -2.60%-626.03M | -2.85%-616.18M | -3.81%-634.85M | -3.68%-623.45M | -4.00%-610.14M | -4.00%-610.14M |
Goodwill and other intangible assets | 0.28%5.34B | 0.28%5.35B | 0.28%5.37B | -0.98%5.31B | -0.98%5.31B | -1.01%5.32B | -1.04%5.34B | -1.07%5.35B | -1.10%5.36B | -1.10%5.36B |
-Goodwill | 1.15%3.02B | 1.15%3.02B | 1.15%3.02B | 0.00%2.98B | 0.00%2.98B | 0.00%2.98B | 0.00%2.98B | 0.00%2.98B | 0.00%2.98B | 0.00%2.98B |
-Other intangible assets | -0.84%2.32B | -0.83%2.34B | -0.81%2.35B | -2.21%2.33B | -2.21%2.33B | -2.26%2.34B | -2.32%2.36B | -2.38%2.37B | -2.45%2.38B | -2.45%2.38B |
Investments and advances | 27.89%46.18M | 2.46%37.88M | 5.09%38.97M | -3.88%35.72M | -3.88%35.72M | -2.74%36.11M | -0.89%36.97M | -1.21%37.09M | -43.80%37.16M | -43.80%37.16M |
Non current accounts receivable | ---- | ---- | ---- | -30.12%9.88M | -30.12%9.88M | -42.54%10.91M | -46.61%11.88M | --12.93M | --14.14M | --14.14M |
Non current deferred assets | --6.52M | 1,432.89%6.9M | 442.43%7.27M | --0 | --0 | --0 | -88.84%450K | -72.77%1.34M | -61.55%2.23M | -61.55%2.23M |
Non current prepaid assets | --7.11M | --7.97M | --8.85M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Defined pension benefit | 6.01%52.55M | 2.67%51.64M | 4.35%51.71M | 3.98%50.87M | 3.98%50.87M | 2.23%49.57M | 2.74%50.3M | -2.49%49.55M | -8.03%48.92M | -8.03%48.92M |
Other non current assets | 28.66%22.69M | 5.12%20.23M | 4.12%22.58M | -29.07%17.06M | -29.07%17.06M | -39.88%17.63M | -37.68%19.24M | -48.11%21.69M | -12.23%24.05M | -12.23%24.05M |
Total non current assets | 0.51%5.98B | 0.32%5.99B | 0.24%6.01B | -1.25%5.95B | -1.25%5.95B | -1.66%5.95B | -1.79%5.97B | -1.49%5.99B | -1.71%6.03B | -1.71%6.03B |
Total assets | 0.05%7.2B | -0.36%7.09B | -3.91%7.1B | -4.49%7B | -4.49%7B | 1.00%7.2B | 2.15%7.12B | 7.88%7.39B | 5.94%7.33B | 5.94%7.33B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 37.52%292.62M | 34.51%244.54M | 10.18%276.75M | 10.87%240.52M | 10.87%240.52M | -2.95%212.79M | -3.21%181.8M | 5.04%251.19M | 18.58%216.94M | 18.58%216.94M |
-accounts payable | 7.06%91.96M | 0.43%79.13M | -9.41%80M | 50.83%114.95M | 50.83%114.95M | 2.49%85.9M | -8.79%78.79M | 1.53%88.31M | 4.41%76.21M | 4.41%76.21M |
-Total tax payable | 2,740.91%55M | 1,181.56%43.78M | 28.88%66.45M | -73.87%6.01M | -73.87%6.01M | -51.47%1.94M | -55.11%3.42M | 9.29%51.56M | 101.27%22.99M | 101.27%22.99M |
-Other payable | 16.57%145.66M | 22.13%121.63M | 17.05%130.3M | 1.54%119.56M | 1.54%119.56M | -4.95%124.95M | 6.14%99.59M | 6.04%111.32M | 19.49%117.74M | 19.49%117.74M |
Current accrued expenses | 23.97%107.76M | 22.27%137.37M | 26.17%108.96M | 3.38%127.93M | 3.38%127.93M | -28.77%86.93M | -15.79%112.35M | -15.47%86.36M | -9.68%123.75M | -9.68%123.75M |
Current liabilities | 30.50%466.71M | 27.96%425.78M | 14.75%433.98M | 8.27%423.37M | 8.27%423.37M | -9.47%357.64M | -10.25%332.74M | -0.42%378.2M | 4.24%391.02M | 4.24%391.02M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -0.10%3.14B | -0.08%3.14B | -0.07%3.14B | -0.07%3.15B | -0.07%3.15B | -0.19%3.14B | -0.25%3.15B | -0.19%3.15B | -5.18%3.15B | -5.18%3.15B |
-Long term debt | 0.12%3.08B | 0.12%3.07B | 0.11%3.07B | 0.11%3.07B | 0.11%3.07B | 0.11%3.07B | 0.11%3.07B | 0.11%3.07B | -5.03%3.07B | -5.03%3.07B |
-Long term capital lease obligation | -9.40%66M | -8.33%68.05M | -7.48%70.94M | -7.26%73.73M | -7.26%73.73M | -11.58%72.85M | -13.12%74.23M | -10.77%76.67M | -10.64%79.5M | -10.64%79.5M |
Non current deferred liabilities | -0.09%576.44M | 0.41%577.33M | 3.74%578.24M | 3.97%578.22M | 3.97%578.22M | 3.87%576.98M | 4.11%574.98M | 1.16%557.39M | 1.41%556.13M | 1.41%556.13M |
Employee benefits | -12.05%64.4M | -7.49%67.89M | -5.23%69.71M | -4.34%70.48M | -4.34%70.48M | 37.98%73.23M | 33.92%73.38M | 30.34%73.55M | 26.90%73.68M | 26.90%73.68M |
Other non current liabilities | -8.23%58.24M | -17.43%55.04M | -11.60%61.04M | -17.59%57.77M | -17.59%57.77M | -14.69%63.46M | -12.50%66.65M | -12.08%69.05M | -11.38%70.1M | -11.38%70.1M |
Total non current liabilities | -0.46%3.84B | -0.45%3.84B | 0.18%3.85B | 0.11%3.85B | 0.11%3.85B | 0.64%3.86B | 0.63%3.86B | 0.21%3.85B | -3.94%3.85B | -3.94%3.85B |
Total liabilities | 2.16%4.31B | 1.80%4.27B | 1.48%4.29B | 0.86%4.28B | 0.86%4.28B | -0.30%4.22B | -0.33%4.19B | 0.16%4.23B | -3.24%4.24B | -3.24%4.24B |
Shareholders'equity | ||||||||||
Share capital | 0.00%324.42M | 0.00%324.42M | 0.00%324.42M | 0.00%324.42M | 0.00%324.42M | 0.00%324.42M | 0.00%324.42M | 0.00%324.42M | 0.00%324.42M | 0.00%324.42M |
-common stock | 0.00%324.42M | 0.00%324.42M | 0.00%324.42M | 0.00%324.42M | 0.00%324.42M | 0.00%324.42M | 0.00%324.42M | 0.00%324.42M | 0.00%324.42M | 0.00%324.42M |
Retained earnings | 4.11%8.39B | 3.65%8.28B | 4.68%8.25B | 2.45%8.09B | 2.45%8.09B | 4.65%8.06B | 5.35%7.99B | 5.35%7.88B | 5.88%7.9B | 5.88%7.9B |
Paid-in capital | -61.44%27.94M | 0.00%27.94M | 0.00%27.94M | 0.00%27.94M | 0.00%27.94M | 159.32%72.46M | 0.00%27.94M | 0.00%27.94M | 0.00%27.94M | 0.00%27.94M |
Less: Treasury stock | 7.11%5.76B | 7.54%5.71B | 14.68%5.68B | 11.20%5.62B | 11.20%5.62B | 6.08%5.38B | 4.54%5.31B | -2.85%4.96B | -2.72%5.05B | -2.72%5.05B |
Gains losses not affecting retained earnings | 5.03%-116.28M | 4.92%-117.39M | 4.79%-118.5M | 4.72%-119.61M | 4.72%-119.61M | -11.04%-122.44M | -11.20%-123.47M | -11.29%-124.46M | -29.13%-125.53M | -29.13%-125.53M |
Total stockholders'equity | -3.01%2.87B | -3.55%2.8B | -11.21%2.8B | -11.94%2.7B | -11.94%2.7B | 2.86%2.96B | 5.92%2.9B | 20.33%3.15B | 21.90%3.07B | 21.90%3.07B |
Noncontrolling interests | 8.00%19.94M | 8.00%19.56M | 8.00%19.17M | 8.00%18.81M | 8.00%18.81M | 8.00%18.46M | 8.00%18.11M | 8.06%17.75M | 7.99%17.42M | 7.99%17.42M |
Total equity | -2.94%2.89B | -3.48%2.82B | -11.11%2.82B | -11.83%2.72B | -11.83%2.72B | 2.89%2.98B | 5.94%2.92B | 20.25%3.17B | 21.81%3.09B | 21.81%3.09B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |